“You say, <<He’s turned down the opportunity to combine leronlimab with another therapeutic in the past>>”

Please expound on why anyone believes this? Was it something he said?”

During a paid interview or a CC, NP mentioned that CYDY had been contacted about combining leronlimab in a trial with another drug. I recall him saying remdesevir, but he may have just generally said that CYDY didn’t believe they needed to combine leronlimab with another drug to show efficacy for leronlimab.